Range Financial Group LLC Has $808,000 Holdings in The Clorox Company (NYSE:CLX)

Range Financial Group LLC raised its stake in The Clorox Company (NYSE:CLX - Free Report) by 223.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 4,972 shares of the company's stock after buying an additional 3,433 shares during the quarter. Range Financial Group LLC's holdings in Clorox were worth $808,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CLX. State Street Corp grew its stake in Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company's stock valued at $1,332,947,000 after purchasing an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC increased its holdings in Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock worth $733,095,000 after buying an additional 4,490,421 shares during the last quarter. Geode Capital Management LLC lifted its stake in Clorox by 1.1% in the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company's stock valued at $491,713,000 after acquiring an additional 33,970 shares during the last quarter. Stifel Financial Corp grew its position in Clorox by 1.7% in the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company's stock worth $380,370,000 after acquiring an additional 37,967 shares in the last quarter. Finally, Nuance Investments LLC raised its holdings in shares of Clorox by 150.6% during the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company's stock valued at $218,035,000 after purchasing an additional 960,094 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Price Performance

Shares of NYSE CLX traded up $2.17 during midday trading on Tuesday, reaching $159.76. 1,246,298 shares of the company traded hands, compared to its average volume of 1,090,152. The firm has a market cap of $19.78 billion, a PE ratio of 55.67, a PEG ratio of 3.04 and a beta of 0.42. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The stock's 50-day simple moving average is $164.64 and its 200-day simple moving average is $155.33. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.64 billion. During the same quarter in the previous year, the company posted $0.49 earnings per share. Clorox's quarterly revenue was up 27.0% compared to the same quarter last year. As a group, equities analysts anticipate that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.05%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox's dividend payout ratio is currently 170.03%.

Analysts Set New Price Targets

Several equities analysts have commented on CLX shares. Wells Fargo & Company upgraded Clorox from an "underweight" rating to an "equal weight" rating and raised their target price for the company from $155.00 to $157.00 in a report on Tuesday. DA Davidson upped their target price on Clorox from $153.00 to $171.00 and gave the stock a "neutral" rating in a research report on Monday, November 4th. Jefferies Financial Group raised shares of Clorox from a "hold" rating to a "buy" rating and lifted their price target for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Barclays upped their price objective on shares of Clorox from $137.00 to $139.00 and gave the stock an "underweight" rating in a report on Friday, November 1st. Finally, TD Cowen raised shares of Clorox from a "sell" rating to a "hold" rating and boosted their target price for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat, Clorox presently has a consensus rating of "Hold" and a consensus price target of $157.46.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.